Editorial Comment
No abstract is available. To read the body of this article, please view the Full Text online.
To access this article, please choose from the options below
PII: S0090-4295(10)00044-0
doi:10.1016/j.urology.2009.12.055
© 2010 Elsevier Inc. All rights reserved.
Refers to article:
- The Use of Zoledronic Acid in Men Receiving Androgen Deprivation Therapy for Prostate Cancer With Severe Osteopenia or Osteoporosis , 19 March 2010
